No Data
No Data
No Data
No Data
No Data
Pharmaceutical Biotech (02269.HK) spent HK$1992 million to buy back 1.57 million shares on April 19
Gelonghui, April 19 | Pharmaceutical Biotech (02269.HK) announced that it spent HK$19.92 million to buy back 1.57 million shares on April 19.
Gelonghui FinanceApr 19 09:16 ET
Trending Industry Today: GENSCRIPT BIO Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 19th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending lower today with 9 constituents down and GENSCRIPT BIO leading Losses.$GENS
moomoo NewsApr 19 03:50 ET
On April 16, Yao Ming Biotech spent HK$198932 million to buy back 1.51 million shares
Pharmaceutical Biotech (02269) announced that on April 16, 2024, the company spent HK$19893,200 to repurchase 1.51 million shares at a repurchase price of HK$12.9-13.42 per share.
新浪港股Apr 16 20:32 ET
Pharmaceutical Biotech (02269.HK) spent HK$19.89 million to buy back 1.51 million shares on April 16
Gelonghui, April 16, 丨 Pharmaceutical Biotech (02269.HK) announced that it spent HK$19.89 million to buy back 1.51 million shares on April 16.
Gelonghui FinanceApr 16 08:23 ET
Pharmaceutical Biotech (02269) spent HK$198932 million to buy back 1.51 million shares on April 16
Yao Ming Biotech (02269) announced that on April 16, 2024, the company spent 198932 million...
Zhitong FinanceApr 16 08:22 ET
On April 11, Yao Ming Biotech spent HK$19.02 million to buy back 1,415,000 shares
Pharmaceutical Biotech (02269) announced that on April 11, 2024, the company spent HK$19.02 million to repurchase 1,415,000 shares at a repurchase price of HK$13.98-14.16 per share.
新浪港股Apr 11 19:42 ET
No Data
No Data